Case Review

Case sharing | fr Nanjing Abel

Case Overview Ball ball Gender: sister Age: 12 Weight: 4. 9kg MMVD: phase C Hello, everyone. My name is Qiuqiu. I'm a cute bear.

2021.11 Dr. Ryan Okonkwo, Senior Veterinary Cardiologist
Case sharing | fr Nanjing Abel

Case Overview

Ball ball
Gender: sister
Age: 12
Weight: 4.9kg
MMVD: phase C

Hello, everyone. My name is Qiuqiu. I'm a cute bear. My favorite thing is to chase and play with my master. But last year, I started coughing and asthma. When I arrived at the hospital, I was diagnosed with canine valve degenerative heart disease (MMVD). When the master knew it, he was also very anxious. After consulting the doctor, the master decided to operate on me. The operation was very successful, I can be with my master again. Thank you for your loving doctor and your persistent master. Let's listen to my story!
 Surgical overview

Before operation, the patient sat on the ball, had shortness of breath and asthma, and coughed sometimes in silence. Doctors diagnosed left atrial dilatation, left ventricular dilatation, mitral valve thickening, mild prolapse, LA / AO = 2, mitral regurgitation area > 30%, mild tricuspid regurgitation, MV e / a > 1, e wave nearly 1m / s, mitral degenerative disease, phase C. And there are three reflux holes. After clamping two of them with v-clamp, the reflux has been significantly improved.

MR was reexamined one month after operation
Two weeks after operation
Postoperative Dr
New treatment

Mitral regurgitation is very common in small dogs in the elderly, with an incidence rate of 20-30%. The occurrence of the disease is related to breed, age and gender. The age of sick dogs is mostly distributed in 5 ~ 16 years old. The disease rate increases with age, mostly in small dogs and male dogs. Canine mitral regurgitation has characteristic night cough, night asthma, weakness, exercise intolerance or fatigue after exercise and excitement, prolonged recovery time, severe purple tongue color, syncope and so on. The survival time of dogs with severe mitral regurgitation is only 3-6 months.

The control effect of traditional drugs is general, which can only alleviate symptoms, can not be cured, and the condition will still gradually worsen. The monthly drug cost ranges from 2000 to 4000 yuan. Or valve replacement. The operation is difficult, high risk, high mortality and expensive. At present, only a few teams in the world have completed individual cases, which can not be popularized in a large area.

Shanghai Hongyu medical v-clamp minimally invasive surgery has high safety, small trauma and fast recovery. It does not need cardiac arrest and cardiopulmonary bypass. It cuts a 2-3cm incision in the precordial area, punctures the heart and sends instruments to complete mitral valve repair, reduces mitral regurgitation, and provides a new technical scheme for the treatment of canine mitral regurgitation.
Hongyu Medical
Case sharing | fr Nanjing Abel · Shanghai HONGYU Medical